2024 -2024 Director, Head of Biology and Pharmacology @
2022 -2024 Associate Director of Biology @
2018 -2022 Senior Scientist @
2018 -2018 Instructor, Meyer Cancer Center @
2012 -2018 Postdoctoral Researcher, Meyer Cancer Center (Cantley Lab) @
2005 -2012 PhD Candidate, Dept. of Pharmacology (Jaffrey Lab) @
2003 -2005 Risk Analyst @
Mark Lundquist Education
Columbia Business School
MBA
2021-2023
Weill Cornell Graduate School of Medical Sciences
PhD, Pharmacology (Pharmacology)
2012
The Johns Hopkins University
Masters, Biotechnology (Biotechnology)
2005
University of Pennsylvania
BSE, Chemical Engineering
Mark Lundquist Summary
Mark Lundquist, based in New York, NY, US, is currently a Head of Late Validation at Ochre Bio. Mark Lundquist brings experience from previous roles at Alphina Therapeutics, Kadmon, a Sanofi Company and Weill Cornell Medicine. Mark Lundquist holds a 2021 - 2023 MBA @ Columbia Business School. Mark Lundquist has 1 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.